Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

BUY
$107.32 - $113.5 $33,161 - $35,071
309 Added 8.33%
4,017 $438,000
Q4 2022

Jan 19, 2023

BUY
$62.39 - $113.8 $231,342 - $421,970
3,708 New
3,708 $0
Q1 2022

Apr 19, 2022

BUY
$86.42 - $109.81 $37,765 - $47,986
437 Added 13.36%
3,708 $390,000
Q1 2021

Apr 23, 2021

BUY
$71.83 - $95.48 $234,955 - $312,315
3,271 New
3,271 $301,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Access Financial Services, Inc. Portfolio

Follow Access Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Access Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Access Financial Services, Inc. with notifications on news.